We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...
HCA Healthcare released Q4 and Full-Year FY 2024 earnings on Jan. 24th, beating consensus for both EPS and Revenue. Click ...
Growing up with an OB-GYN father, Rachel Blank assumed that most women received excellent gynecological care. In 2024, Allara ...
Duaa Eldeib, Maya Miller, Annie Waldman and Max Blau ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The U.S.
An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...
Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for The Cigna Group in a report issued on Tuesday, ...
In their first test without ace spiker Ces Molina and middle blocker Riri Meneses, the Cignal HD Spikers showed strength ...
Buying $1000 In CI: If an investor had bought $1000 of CI stock 20 years ago, it would be worth $11,032.06 today based on a ...
We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a look at where The Cigna Group (NYSE:CI) stands against the other large-cap ...
Brown University School of Public Health and Brookings Institution researchers have conducted a longitudinal and ...
Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.